论文信息 - A randomized double-blind phase III study of nimorazole as a hypoxic radiosensitizer of primary radiotherapy in supraglottic larynx and pharynx carcinoma . Results of the Danish Head and Neck Cancer Study ( DAHANCA ) Protocol 585 - 字舞流文

A randomized double-blind phase III study of nimorazole as a hypoxic radiosensitizer of primary radiotherapy in supraglottic larynx and pharynx carcinoma . Results of the Danish Head and Neck Cancer Study ( DAHANCA ) Protocol 585

Jens Overgaarda | Hanne Sand Hansenb | Marie Overgaardc | Lars Bastholtd | Anne Berthelsene | Lena Spechte | Birgit Lindeløvb | Karsten Jørgensenf